MR-skanning af diabetisk kardiomyopati

Per Lav Madsen; Annemie Stege Bojer; Martin Sørensen; Peter Gæde

MR-skanning af diabetisk kardiomyopati

Per Lav Madsen^*, Annemie Stege Bojer, Martin Sørensen, Peter Gæde

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Downloads (Pure)

Abstract

Overweight and diabetes (DM) result in premature cardiovascular disease. Even if unaccompanied by ischaemic heart disease, DM stiffens the circulation, which may result in heart failure with preserved ejection fraction. Magnetic resonance imaging studies have documented cardiac hypertrophy, myocardial vascular rarefaction, and myocardial fibrosis in patients with type 2 DM. All three phenotypical changes seem noteworthy targets for early intervention. “Diabetic cardiomyopathy” is years underway and hence early detection may be needed to secure adequate treatment of the metabolic syndrome.

Originalsprog	Dansk
Artikelnummer	V04220237
Tidsskrift	Ugeskrift for Læger
Vol/bind	184
Udgave nummer	20A
Antal sider	7
ISSN	0041-5782
Status	Udgivet - 17. okt. 2022

Bibliografisk note

Publisher Copyright:
© 2022,Ugeskrift for Laeger. All Rights Reserved.

Dokumenter og links

Open Access VersionForlagets udgivne version, 257 KBLicens: CC BY-NC-ND

https://ugeskriftet.dk/videnskab/mr-skanning-af-diabetisk-kardiomyopatiLicens: CC BY-NC-ND

Citationsformater

@article{a351a9b26391483f9ecddbdc7273f246,

title = "MR-skanning af diabetisk kardiomyopati",

abstract = "Overweight and diabetes (DM) result in premature cardiovascular disease. Even if unaccompanied by ischaemic heart disease, DM stiffens the circulation, which may result in heart failure with preserved ejection fraction. Magnetic resonance imaging studies have documented cardiac hypertrophy, myocardial vascular rarefaction, and myocardial fibrosis in patients with type 2 DM. All three phenotypical changes seem noteworthy targets for early intervention. “Diabetic cardiomyopathy” is years underway and hence early detection may be needed to secure adequate treatment of the metabolic syndrome.",

author = "Madsen, {Per Lav} and Bojer, {Annemie Stege} and Martin S{\o}rensen and Peter G{\ae}de",

year = "2022",

month = oct,

day = "17",

language = "Dansk",

volume = "184",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "20A",

}

TY - JOUR

T1 - MR-skanning af diabetisk kardiomyopati

AU - Madsen, Per Lav

AU - Bojer, Annemie Stege

AU - Sørensen, Martin

AU - Gæde, Peter

PY - 2022/10/17

Y1 - 2022/10/17

N2 - Overweight and diabetes (DM) result in premature cardiovascular disease. Even if unaccompanied by ischaemic heart disease, DM stiffens the circulation, which may result in heart failure with preserved ejection fraction. Magnetic resonance imaging studies have documented cardiac hypertrophy, myocardial vascular rarefaction, and myocardial fibrosis in patients with type 2 DM. All three phenotypical changes seem noteworthy targets for early intervention. “Diabetic cardiomyopathy” is years underway and hence early detection may be needed to secure adequate treatment of the metabolic syndrome.

AB - Overweight and diabetes (DM) result in premature cardiovascular disease. Even if unaccompanied by ischaemic heart disease, DM stiffens the circulation, which may result in heart failure with preserved ejection fraction. Magnetic resonance imaging studies have documented cardiac hypertrophy, myocardial vascular rarefaction, and myocardial fibrosis in patients with type 2 DM. All three phenotypical changes seem noteworthy targets for early intervention. “Diabetic cardiomyopathy” is years underway and hence early detection may be needed to secure adequate treatment of the metabolic syndrome.

M3 - Tidsskriftartikel

AN - SCOPUS:85140601393

SN - 0041-5782

VL - 184

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 20A

M1 - V04220237

ER -